Investigation Report on China's Insulin Aspart Market, 2018-2022

Publisher Name :
Date: 01-Nov-2018
No. of pages: 30

Description

The rapid development of the Chinese economy in the past three decades has changed people's dietary habits and reduced physical activities, which leads to an increasing incidence of obesity-related diseases. It is estimated that at the end of 2017, there were more than 100 million diabetic patients in China. The market size of diabetes drugs is also growing in China.

On Dec. 26, 2001, Novo Nordisk announced that Insulin Aspart (trade name: NovoRapid), the first and only insulin analog that can be used with insulin pumps, was approved by the FDA. Insulin Aspart starts working in 10 to 20 minutes after subcutaneous injection and can reduce postprandial blood glucose and glycated hemoglobin (HbA1c). On the basis of Insulin Aspart, Novo Nordisk developed premixed insulin aspart containing soluble insulin aspart and protaminated insulin aspart of various proportions. The combination of the fast-acting form and the long-acting form allows patients to receive fewer injections over the course of the day. NovoLog Mix 70/30, containing 30% soluble insulin aspart and 70% protaminated insulin aspart, was approved by the FDA in Nov. 2001. Similar NovoLog Mix 50/50 was approved by the FDA in Aug. 2008. In Apr. 2005, NovoMix 30 (30% soluble insulin aspart and 70% protaminated insulin aspart), the first premixed insulin analog, was launched in China. According to CRI, from 2005 to 2017, the sales value of Insulin Aspart in China grew by over 100 times. The market size of Insulin Aspart in China exceeded CNY 200 million in 2017.

Because there are high technical barriers against the imitation of Insulin Aspart, by Oct. 2018, China's Insulin Aspart market is monopolized by Novo Nordisk's Insulin Aspart (NovoRapid). According to CRI, several Chinese companies are applying for the CFDA's approval for generic Insulin Aspart. However, the launch of generic drugs will take several years. With an increasing number of diabetic patients, the market size of Insulin Aspart in China will maintain rapid growth in the next few years.

Topics Covered:


  • Situation of diabetes in China

  • Sales of Insulin Aspart in China

  • Prices of Insulin Aspart in China

  • Progress of generic Insulin Aspart in China

  • Prospect of China's Insulin Aspart market from 2018 to 2022

Investigation Report on China's Insulin Aspart Market, 2018-2022

Table of Contents

1 Relevant Concepts of Insulin Aspart
1.1 Indications for Insulin Aspart
1.2 Development of Insulin Aspart in China
1.3 Patents and Government Approval on Insulin Aspart in China

2 Sales of Insulin Aspart in China, 2013-2017
2.1 Sales Value of Insulin Aspart
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Insulin Aspart
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Insulin Aspart by Dosage Form in China, 2013-2017

3 Analysis on Major Insulin Aspart Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Major Insulin Aspart Manufacturers
3.2 Novo Nordisk
3.2.1 Enterprise Profile
3.2.2 Sales of Novo Nordisk's Insulin Aspart in China

4 Prices of Insulin Aspart in China, 2017-2018
4.1 Novo Nordisk (NovoRapid)
4.2 Progress of Generic Drugs

5 Prospect of China's Insulin Aspart Market, 2018-2022
5.1 Forecast on Market Size
5.2 Forecast on Market Trend

List of Charts

Chart Sales of Insulin Aspart in China, 2013-2017
Chart Sales Value of Insulin Aspart in Parts of China, 2013-2017
Chart Sales Volume of Insulin Aspart in China, 2013-2017
Chart Sales Volume of Insulin Aspart in Parts of China, 2013-2017
Chart Sales Value of Insulin Aspart Injections in China, 2013-2017
Chart Sales Volume of Insulin Aspart Injections in China, 2013-2017
Chart Sales Value of Novo Nordisk's Insulin Aspart (NovoRapid), 2013-2017
Chart Sales Volume of Novo Nordisk's Insulin Aspart (NovoRapid), 2013-2017
Chart Prices of Novo Nordisk's Insulin Aspart (NovoRapid) in Parts of China in 2017

  • Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 11-Dec-2018        Price: US 3480 Onwards        Pages: 132
    Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of medicine that lower high blood glucose levels and are used in the treatment of type 2 diabetes. Scope of the Report: This report focuses on the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The worldwide market for D......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market 2018, Forecast to 2023
    Published: 11-Dec-2018        Price: US 4880 Onwards        Pages: 130
    Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of medicine that lower high blood glucose levels and are used in the treatment of type 2 diabetes. Scope of the Report: This report focuses on the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The worldwide market for D......
  • Global and Chinese Glucagon Like Peptide-1 (GLP-1) Agonists Industry, 2018 Market Research Report
    Published: 08-Dec-2018        Price: US 3000 Onwards        Pages: 139
    The 'Global and Chinese Glucagon Like Peptide-1 (GLP-1) Agonists Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Glucagon Like Peptide-1 (GLP-1) Agonists industry with a focus on the Chinese market. The report provides key statistics on the market status of the Glucagon Like Peptide-1 (GLP-1) Agonists manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstl......
  • Global and Chinese Insulin Lispro Industry, 2018 Market Research Report
    Published: 07-Dec-2018        Price: US 3000 Onwards        Pages: 140
    The 'Global and Chinese Insulin Lispro Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Insulin Lispro industry with a focus on the Chinese market. The report provides key statistics on the market status of the Insulin Lispro manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definiti......
  • Global Repaglinide Market Insights, Forecast to 2025
    Published: 07-Dec-2018        Price: US 3900 Onwards        Pages: 119
    Repaglinide is a benzoic acid derivative and is used in the therapy of type 2 diabetes. The global Repaglinide market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Repaglinide market based on company, product type, end user and key regions. This report studies the global market size of Repaglinide in key regions ......
  • Global and Chinese Acarbose Industry, 2018 Market Research Report
    Published: 05-Dec-2018        Price: US 3000 Onwards        Pages: 147
    The 'Global and Chinese Acarbose Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Acarbose industry with a focus on the Chinese market. The report provides key statistics on the market status of the Acarbose manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, applications a......
  • Global Insulin Detemir Market Insights, Forecast to 2025
    Published: 05-Dec-2018        Price: US 3900 Onwards        Pages: 116
    In 2017, the global Insulin Detemir market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Insulin Detemir market based on company, product type, application and key regions. This report studies the global market size of Insulin Detemir in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the c......
  • Global and Chinese Insulin Glargine Industry, 2018 Market Research Report
    Published: 30-Nov-2018        Price: US 3000 Onwards        Pages: 135
    The 'Global and Chinese Insulin Glargine Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Insulin Glargine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Insulin Glargine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its de......
  • Investigation Report on China’s Glimepiride Market, 2018-2022
    Published: 29-Nov-2018        Price: US 2200 Onwards        Pages: 30
    Glimepiride is a third-generation sulfonylurea insulin secretagogue. Sanofi’s brand-name drug (trade name: Amaryl) have been marketed in many countries after it was approved by the FDA (U.S. Food and Drug Administration) on Nov. 30, 1995. Glimepiride is the sulfonylurea hypoglycemic agent that has best clinical effectiveness as well as the first sulfonylurea approved by the FDA to be used together with insulin. It does much better in sensitizing and simulati......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs